Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Hemochromatosis International Taskforce: Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype (2018)

Canada

●Choosing Wisely Canada: Don't order HFE genotyping based on serum ferritin values alone to diagnose hereditary hemochromatosis (updated 2017)

●BC Guidelines: HFE-associated hereditary hemochromatosis investigations and management (2013)

United States

●American College of Gastroenterology (ACG): Clinical guideline on hereditary hemochromatosis (2019)

●Choosing Wisely: Don't order HFE genetic testing for a patient without iron overload or a family history of HFE-associated hereditary hemochromatosis (2015, updated 2016)

●American Association for the Study of Liver Diseases (AASLD): Practice guideline for the diagnosis and management of hemochromatosis (2011)

Europe

●European Molecular Quality Network (EMQN): Best practice guideline for the molecular genetic diagnosis of hereditary hemochromatosis (HH) (2016)

●European Association for the Study of the Liver (EASL): Clinical practice guidelines on HFE hemochromatosis (2010)

United Kingdom

●British Society for Haematology (BSH): Diagnosis and therapy of genetic haemochromatosis, 2017 update (published 2018)